2000
DOI: 10.1002/(sici)1097-0142(20000115)88:2<245::aid-cncr1>3.0.co;2-t
|View full text |Cite
|
Sign up to set email alerts
|

Immunohistochemical study of MUC1 mucin in premalignant oral lesions and oral squamous cell carcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

8
50
1

Year Published

2002
2002
2013
2013

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 54 publications
(59 citation statements)
references
References 32 publications
8
50
1
Order By: Relevance
“…MVD has been reported to be correlated with regional recurrence in T 1-3 N 0 oral cavity squamous cell carcinoma (12). MUC1 is a mucin-like glycoprotein encoded by the MUC1 gene and has been reported to be correlated with lymph node metastasis in oral squamous cell carcinoma (13). COX-2 has been found to be up-regulated in head and neck carcinoma (14) and has been shown to increase tumor metastasis potential (15).…”
Section: Introductionmentioning
confidence: 99%
“…MVD has been reported to be correlated with regional recurrence in T 1-3 N 0 oral cavity squamous cell carcinoma (12). MUC1 is a mucin-like glycoprotein encoded by the MUC1 gene and has been reported to be correlated with lymph node metastasis in oral squamous cell carcinoma (13). COX-2 has been found to be up-regulated in head and neck carcinoma (14) and has been shown to increase tumor metastasis potential (15).…”
Section: Introductionmentioning
confidence: 99%
“…During this process, loss of metastasis suppressor gene(s) function should be a crucial step in the progression of cancer cells from a nonmetastatic to a metastatic phenotype. Recent studies have identified the correlation between gene expression patterns and lymph node metastasis in OSCC (2,3). Yet, there is no critical determinant that can be used to identify which primary lesions will develop into metastatic OSCC.…”
Section: Introductionmentioning
confidence: 99%
“…It has previously been noted that autoimmune responses to cancer-specific antigens such as MUC1 and cyclin B1 can be identified in healthy donor populations; therefore, we decided to further characterize humoral immune function in CLL patients. [18][19][20] Although the majority of CLL patients maintained detectable LCP1-specific IgG, only 6 of 12 were able to mount an identifiable IgG response to the vaccinated (Table 1). (E) ELISA analysis of LCP1-specific IgG in 33 previously untreated CLL patients and 6 healthy donor controls.…”
Section: Mass Spectroscopy Of Autoimmune Igg Responses Identifies Lcpmentioning
confidence: 99%